BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Lux Biosciences 



New York City  New York    U.S.A.
Phone: 917-518-2875 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Start Up





 Company News
Isotechnika Pharma Inc. (ISA.TO) Announces That Lux Biosciences' Phase 3 Uveitis Study Did Not Meet Primary Endpoint 12/27/2012 8:44:57 AM    More...
Isotechnika Pharma Inc. (ISA.TO)'s Partner Lux Biosciences Completes Enrollment in Phase 3 Uveitis Study 7/9/2012 9:09:10 AM    More...
Lux Biosciences Receives Complete Response Letter from FDA for Luveniq(TM) 8/4/2010 12:19:56 PM    More...
Lux Biosciences, Isotechnika Pharma Inc. (ISA.TO) Receive Complete Response Letter from FDA for Voclosporin; FDA Requests Additional Information and Clinical Trial; Isotechnika Shares Dive 32.56% at 1:22PM EDT 8/4/2010 7:46:15 AM    More...
Lux Biosciences Names Dean Mitchell President and CEO 7/1/2010 6:59:27 AM    More...
FDA Cancels Advisory Committee Meeting for Coclosporin; Priority Review of Lux Biosciences' NDA Continues 6/23/2010 7:28:35 AM    More...
Lux Biosciences' Luveniq Receives FDA Priority Review 3/30/2010 7:01:33 AM    More...
Lux Biosciences Receives Acceptance of Luveniq(TM) MAA Filing from European Medicines Evaluation Agency 3/2/2010 11:04:16 AM    More...
Lux Biosciences Files for LUVENIQ(TM) Approval in US and Europe for Noninfectious Uveitis 2/4/2010 10:44:45 AM    More...
Lux Biosciences to Present at Lazard Capital Markets 6th Annual Healthcare Conference 11/16/2009 9:34:46 AM    More...
123456